Incyte Corp. (INCY)
121.70
-0.57
(-0.47%)
USD |
NASDAQ |
Nov 12, 16:00
121.72
+0.02
(+0.02%)
After-Hours: 20:00
Incyte Market Cap : 24.83B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 24.83B |
| November 11, 2026 | 24.94B |
| November 10, 2026 | 24.54B |
| November 09, 2026 | 24.87B |
| November 06, 2026 | 24.41B |
| November 05, 2026 | 24.07B |
| November 04, 2026 | 25.06B |
| November 03, 2026 | 23.99B |
| November 02, 2026 | 24.49B |
| October 30, 2026 | 24.56B |
| October 29, 2026 | 23.83B |
| October 28, 2026 | 23.84B |
| October 27, 2026 | 23.79B |
| October 26, 2026 | 22.77B |
| October 23, 2026 | 23.26B |
| October 22, 2026 | 23.50B |
| October 21, 2026 | 22.80B |
| October 20, 2026 | 23.44B |
| October 19, 2026 | 22.76B |
| October 16, 2026 | 22.72B |
| October 15, 2026 | 22.76B |
| October 14, 2026 | 22.42B |
| October 13, 2026 | 21.83B |
| October 12, 2026 | 22.38B |
| October 09, 2026 | 22.67B |
| Date | Value |
|---|---|
| October 08, 2026 | 22.66B |
| October 07, 2026 | 22.80B |
| October 06, 2026 | 22.66B |
| October 05, 2026 | 22.94B |
| October 02, 2026 | 23.17B |
| October 01, 2026 | 23.54B |
| September 30, 2026 | 24.39B |
| September 29, 2026 | 24.76B |
| September 28, 2026 | 25.09B |
| September 25, 2026 | 24.90B |
| September 24, 2026 | 25.01B |
| September 23, 2026 | 25.05B |
| September 22, 2026 | 25.51B |
| September 21, 2026 | 25.05B |
| September 18, 2026 | 25.18B |
| September 17, 2026 | 25.65B |
| September 16, 2026 | 25.07B |
| September 15, 2026 | 24.47B |
| September 14, 2026 | 24.56B |
| September 11, 2026 | 24.41B |
| September 10, 2026 | 24.78B |
| September 09, 2026 | 25.33B |
| September 08, 2026 | 25.00B |
| September 04, 2026 | 25.47B |
| September 03, 2026 | 25.73B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Regeneron Pharmaceuticals, Inc. | 98.35B |
| Mirum Pharmaceuticals, Inc. | 6.086B |
| AbbVie, Inc. | 520.44B |
| Alnylam Pharmaceuticals, Inc. | 20.97B |
| Biogen, Inc. | 37.02B |
Market Cap Related Metrics
| PE Ratio | 64.76 |
| PS Ratio | 4.166 |
| Price to Book Value | 4.400 |
| Price to Free Cash Flow | 36.83 |
| Price | 121.70 |
| Earnings Yield | 1.54% |
| Operating PE Ratio | 35.72 |
| Normalized PE Ratio | 57.32 |